ArticleJTCVS open2025
Transposition of the great arteries with ventricular septal defect and pulmonary stenosis: Hemodynamic simulation for palliative strategies.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Left ventricular outflow tract stenting in late presenting transposition physiology with ventricular shunt and pulmonary stenosis: a case series.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transposition of the great arteries (TGA) with ventricular septal defect (VSD) and pulmonary stenosis (PS) presents complex hemodynamic challenges, frequently requiring staged palliative interventions. To inform optimal treatment strategies, we developed computational cardiovascular models to simulate the hemodynamics of TGA/VSD/PS. Methods: These models yielded critical hemodynamic parameters, including systemic oxygenation, pulmonary-to-systemic flow ratio (Qp/Qs), and mean pulmonary artery pressure (mPAP). By modulating resistances of the atrial septal defect (ASD), systemic-to-pulmonary shunt (SPS), and PS, we evaluated the impacts of diverse palliative interventions, such as ASD enlargement, SPS placement, and pulmonary artery banding (PAB). Results: Our model with severe PS revealed that a moderate or larger ASD or SPS is indispensable for achieving adequate blood mixing and systemic oxygenation. Both ASD enlargement and SPS placement enhanced oxygenation; however, ASD enlargement resulted in a smaller increase in Qp/Qs and a reduction in mPAP, fostering hemodynamic stability. The combined application of SPS and PAB demonstrated superior efficacy in reducing Qp/Qs and mPAP compared to SPS placement alone. The analysis of ASD flow patterns revealed that an inadequate ASD size accentuated the late component of ventricular systolic left-to-right flow (σ-wave), resulting in a square-shaped pattern, independent of SPS or PS. Echocardiographic flow patterns thus present a clinical reliable indicator of ASD adequacy beyond morphologic assessment. Conclusions: These findings support a palliative treatment strategy in which percutaneous ASD enlargement is prioritized, guided by echocardiographic ASD flow patterns. If adequate ASD enlargement cannot be achieved, SPS placement should be performed, with concomitant consideration of PAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.